tiprankstipranks
Core Laboratories N.V. (CLB)
NYSE:CLB
Want to see CLB full AI Analyst Report?

Core Laboratories (CLB) Price & Analysis

224 Followers

CLB Stock Chart & Stats

$16.27
-$0.34(-1.84%)
At close: 4:00 PM EST
$16.27
-$0.34(-1.84%)

Bulls Say, Bears Say

Bulls Say
Geopolitical TensionsPotential easing of geopolitical tensions between Russia and Ukraine could serve as a positive catalyst for the company.
Research And DevelopmentThe Research and Development division is expected to grow, likely outpacing international upstream capital expenditure growth.
Bears Say
Production Enhancement ChallengesProduction Enhancement has shrunk to just 11% of total company operating income, indicating challenges in that segment.

Core Laboratories News

CLB FAQ

What was Core Laboratories N.V.’s price range in the past 12 months?
Core Laboratories N.V. lowest stock price was $9.72 and its highest was $20.36 in the past 12 months.
    What is Core Laboratories N.V.’s market cap?
    Core Laboratories N.V.’s market cap is $606.63M.
      When is Core Laboratories N.V.’s upcoming earnings report date?
      Core Laboratories N.V.’s upcoming earnings report date is Jul 29, 2026 which is in 44 days.
        How were Core Laboratories N.V.’s earnings last quarter?
        Core Laboratories N.V. released its earnings results on Apr 29, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.095 by -$0.035.
          Is Core Laboratories N.V. overvalued?
          According to Wall Street analysts Core Laboratories N.V.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Core Laboratories N.V. pay dividends?
            Core Laboratories N.V. pays a Quarterly dividend of $0.01 which represents an annual dividend yield of 0.24%. See more information on Core Laboratories N.V. dividends here
              What is Core Laboratories N.V.’s EPS estimate?
              Core Laboratories N.V.’s EPS estimate is 0.11.
                How many shares outstanding does Core Laboratories N.V. have?
                Core Laboratories N.V. has 46,096,684 shares outstanding.
                  What happened to Core Laboratories N.V.’s price movement after its last earnings report?
                  Core Laboratories N.V. reported an EPS of $0.06 in its last earnings report, missing expectations of $0.095. Following the earnings report the stock price went down -15.319%.
                    Which hedge fund is a major shareholder of Core Laboratories N.V.?
                    Currently, no hedge funds are holding shares in CLB
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Core Laboratories N.V.

                      Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.

                      Core Laboratories (CLB) Earnings & Revenues

                      CLB Earnings Call

                      Q1 2026
                      0:00 / 0:00
                      Earnings Call Sentiment|Negative
                      The call mixed clear operational and technological strengths (notable product wins, digital data progress, continued shareholder returns and a constructive multi‑year market outlook) with acute near-term headwinds. Q1 showed meaningful sequential revenue declines, sharp margin compression and steep earnings deterioration driven by the Middle East conflict, Russia/Ukraine disruptions, severe weather and higher costs—offset only partially by product/diagnostic demand in select regions and ongoing capital returns. Management expects modest sequential improvement in Q2 but the near-term outlook is still clouded by geopolitical and operational uncertainty.View all CLB earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Flotek
                      Oil States International
                      Tetra Technologies
                      Propetro Holding
                      ProFrac Holding

                      Ownership Overview

                      1.09%35.15%36.71%2.40%
                      36.71% Other Institutional Investors
                      2.40% Public Companies and
                      Individual Investors
                      Popular Stocks